1. Global Probiotics Strain Market Insight Analysis
The global probiotics strain market revenue is expected to reach $1,926.18 million USD by 2024, with a Compound Annual Growth Rate (CAGR) of 8.65% from 2024 to 2033.
Probiotics strains are live microorganisms that confer health benefits when administered in appropriate concentrations. These strains, including species of Bifidobacterium, Lactobacillus, Saccharomyces, and Bacillus, are widely used in supplements, food and beverage products, pharmaceuticals, and animal feed. They are known for their ability to enhance gastrointestinal health, suppress pathogens, improve lactose intolerance, reduce serum cholesterol, and even exhibit anti-tumor effects.
Figure Global Probiotics Strain Market Size (M USD) and CAGR (2024-2033)
2. Driving and Limiting Factors of Probiotics Strain Market Growth
The growth of the global probiotics strain market is influenced by several key factors. On the positive side, the increasing awareness of health benefits associated with probiotics is a major driver. Consumers are becoming more proactive about their digestive health, leading to a higher demand for probiotic-fortified foods and supplements. The expanding food and beverage industry, particularly in emerging markets like Asia Pacific, is also contributing to the market’s growth. The region’s rapid economic development, rising disposable incomes, and increasing urbanization have led to a greater demand for nutritional products, making it the fastest-growing market for probiotics strains.
Another significant driver is the growing demand from key applications such as food and beverages, animal feed, and dietary supplements. The popularity of probiotic functional foods and beverages is on the rise, as consumers seek products that offer both nutrition and health benefits. Additionally, the increasing prevalence of gastrointestinal disorders and the need for preventive healthcare solutions are fueling the market’s expansion.
However, the market also faces certain challenges. One of the primary limiting factors is the complex regulatory environment. International quality standards and regulations for probiotic products, enforced by organizations such as the FDA, WHO, and EU Parliament, can be stringent and vary by region. This complexity can hinder the market’s growth, especially for smaller players. Another challenge is the integration of probiotics into functional foods, which can be technically difficult and expensive. Probiotic strains are sensitive to changes in pH and temperature, and maintaining their viability throughout the product’s shelf life is a significant challenge.
Moreover, the risk of contamination poses a threat to the production of probiotic products. The live nature of these microorganisms means that they are susceptible to contamination by undesirable microbes, which can lead to the loss of entire batches. High investment costs for research and development, as well as the need for skilled professionals, further limit the market’s growth. Despite these challenges, the overall outlook for the probiotics strain market remains positive, driven by growing consumer demand and technological advancements.
3. Technology Innovation and Corporate Mergers and Acquisitions in Probiotics Strain Market
The probiotics strain market is characterized by significant technological innovation and strategic corporate activities. Companies are continuously investing in research and development to create more effective and stable probiotic strains. Advances in delivery systems, such as microencapsulation and controlled-release formulations, are enhancing the efficacy and shelf life of probiotic products. These innovations are crucial for ensuring that probiotics remain viable and effective throughout their journey from production to consumption.
Chr. Hansen acquired UAS Laboratories LLC in June 2020 to strengthen its microbial platform and probiotic production capabilities. This acquisition aligns with Chr. Hansen’s strategy of pursuing bolt-on acquisitions that fit into its microbial platform, enhancing its global presence and product offerings. Other notable acquisitions include Lallemand’s purchase of Biotec BetaGlucans AS and Probi’s investment in Vital Nutrients Holdings, both aimed at expanding their respective product ranges and market presence.
4. Global Probiotics Strain Market Size by Type
Probiotics strains are live microorganisms that confer health benefits when administered in appropriate concentrations. These strains are widely used in various industries, including food and beverages, dietary supplements, animal feed, and pharmaceuticals.
Lactobacillus acidophilus is a type of bacteria found in the intestines and is known for its health benefits. It produces lactic acid through the enzyme lactase, which helps in maintaining a healthy gut environment. This strain is commonly used in probiotic supplements and fermented foods to support digestive health. In 2024, the revenue for Lactobacillus acidophilus is projected to be 458.25 million USD.
Lactobacillus rhamnosus GG is a well-known probiotic strain that naturally exists in the human intestines. It is used to prevent the growth of harmful bacteria in the stomach and intestines. This strain is highly regarded for its ability to survive in harsh gastrointestinal conditions and provide significant health benefits. In 2024, the revenue for Lactobacillus rhamnosus GG is estimated to be 302.27 million USD.
Bifidobacterium bifidum is a common probiotic bacterium found in the human gut. It is known for its role in maintaining a healthy gut microbiota and supporting overall digestive health. This strain is widely used in probiotic supplements and functional foods. In 2024, the revenue for Bifidobacterium bifidum is projected to be 873.37 million USD.
Table Global Probiotics Strain Market Size by Type in 2024
Market Size (M USD) 2024 | Market Share | |
Lactobacillus acidophilus | 458.25 | 23.79% |
Lactobacillus rhamnosus GG | 302.27 | 15.69% |
Bifidobacterium bifidum | 873.37 | 45.34% |
Others | 292.28 | 15.17% |
5. Global Probiotics Strain Market Size by Application
The food and beverage industry is the largest application segment for probiotics strains. Probiotics are used in various food products, including yogurt, fermented milk, and functional beverages, to enhance nutritional value and support digestive health. In 2024F, the revenue for probiotics in food and beverages is projected to be 1451.24 million USD.
Probiotics strains are also used in animal feed to improve gut health and enhance the overall well-being of livestock. These strains help in preventing gastrointestinal disorders and improving feed efficiency. In 2024F, the revenue for probiotics in animal feed is estimated to be 52.76 million USD.
Dietary supplements are another significant application area for probiotics strains. These supplements are used to support digestive health, immune function, and overall well-being. In 2024F, the revenue for probiotics in dietary supplements is projected to be 305.61 million USD.
Table Global Probiotics Strain Market Size by Application in 2024
Application | Market Size (M USD) 2024 | Market Share |
Food and Beverages | 1451.24 | 75.34% |
Animal Feed | 52.76 | 2.74% |
Dietary Supplement | 305.61 | 15.87% |
Others | 116.57 | 6.05% |
6. Global Probiotics Strain Market by Top Regions
Asia Pacific stands out as the largest market by revenue, with a projected market size of $806.39 million USD in 2024. This region’s dominance is attributed to its rapid economic growth, rising disposable incomes, and increasing demand for health and wellness products. However, Asia Pacific is not just the largest market; it is also the fastest-growing region. The market is expected to expand at a CAGR of 9.68% from 2024 to 2033.
In contrast, Europe is another significant market, with a projected size of $432.50 million USD in 2024. Europe’s market growth is driven by the high consumption of fermented milk products and other probiotic-rich foods. The region’s strong focus on health and wellness, coupled with a well-established food and beverage industry, supports the continuous growth of the probiotics strain market.
North America, with a projected market size of $564.52 million USD in 2024, is another major player. The United States and Canada are key markets within this region, driven by high consumer awareness and demand for health products.
The Middle East & Africa region is also growing, with a projected market size of $122.76 million USD in 2024.
Figure Global Probiotics Strain Market Size by Region in 2024
7. Global Probiotics Strain Market Analysis by Major Players
7.1 Dupont
Introduction and Business Overview: Dupont is a leading global company with a strong presence in biotechnology and the manufacture of chemicals and pharmaceuticals. Founded in 1897 and headquartered in the United States, Dupont offers a wide range of industrial chemicals, synthetic fibers, pharmaceuticals, and agricultural chemicals. The company’s probiotics division, Danisco, specializes in high-quality probiotic strains and ingredients.
Products Offered: Dupont’s probiotics portfolio includes the HOWARU® brand, which offers clinically documented premium probiotic products. Key strains include Lactobacillus acidophilus NCFM®, Bifidobacterium lactis HN019™, and Lactobacillus rhamnosus HN001™. These strains are used in various applications, including dietary supplements, food and beverages, and animal feed.
7.2 Chr. Hansen
Introduction and Business Overview: Chr. Hansen is a global leader in natural ingredients, with a focus on cultures, enzymes, probiotics, and natural colors. Founded in 1874 and headquartered in Denmark, the company offers products for the food, nutritional, pharmaceutical, and agricultural industries. Chr. Hansen is known for its extensive research and development efforts, resulting in a wide range of high-quality probiotic strains.
Products Offered: Chr. Hansen’s probiotics portfolio includes well-documented strains such as Lactobacillus rhamnosus LGG®, Bifidobacterium BB-12®, and Lactobacillus acidophilus DDS-1®. These strains are used in various applications, including dietary supplements, food and beverages, and infant formulas.
7.3 Lallemand
Introduction and Business Overview: Lallemand is a privately owned company founded in 1915 and headquartered in Canada. The company specializes in the research, development, production, and marketing of yeasts, bacteria, and related products. Lallemand’s focus is on optimizing natural fermentation processes in various industries, including food, beverage, and health.
Products Offered: Lallemand offers a range of probiotic strains, including L. plantarum ROSELLA, B.subtilis Rosell-179, and L. helveticus LAFTI L10. These strains are used in various applications, including dietary supplements, functional foods, and animal feed.